Statistics
Total Visits
| Views | |
|---|---|
| A Molecular and Preclinical Comparison of the PD-1 targeted T cell Checkpoint Inhibitors Nivolumab and Pembrolizumab | 229 |
Total Visits Per Month
| July 2020 | August 2020 | September 2020 | October 2020 | November 2020 | December 2020 | January 2021 | |
|---|---|---|---|---|---|---|---|
| A Molecular and Preclinical Comparison of the PD-1 targeted T cell Checkpoint Inhibitors Nivolumab and Pembrolizumab | 2 | 1 | 1 | 0 | 6 | 1 | 2 |
File Downloads
| Views | |
|---|---|
| Fessas_et_al-2017-Seminars_in_Oncology-VoR.pdf | 131 |
| Fessas_Lee_Ikemizu_Janowitz_SeminarsOnc_Nivo_Pembro_2017.docx | 1 |
Top country views
| Views | |
|---|---|
| United States | 83 |
| France | 24 |
| Israel | 24 |
| Germany | 19 |
| China | 12 |
| Japan | 12 |
| United Kingdom | 11 |
| Turkey | 5 |
| AP | 2 |
| Australia | 2 |
Top cities views
| Views | |
|---|---|
| Ashburn | 24 |
| Rishon Le Zion | 19 |
| Fairfield | 16 |
| Princeton | 12 |
| Tokyo | 8 |
| Cambridge | 5 |
| Istanbul | 5 |
| Boardman | 4 |
| Narita | 4 |
| Beijing | 3 |